Business & Tech

One of Nation's Top Doctors Opens Office in Moorestown

Jeffrey P. Carpenter's new office is on Marter Avenue.

Moorestown, NJ -- One of the top vascular and endovascular surgeons in the nation as rated by U.S. News and World Report is opening a practice in Moorestown.

Jeffrey P. Carpenter, MD, Chairman and Chief of the Department of Surgery and Vice President of Perioperative Services at Cooper University Health Care and a Moorestown resident, has opened a new office located at 110 Marter Avenue, Building 500, Suite 503, Moorestown.

He is ranked in the top 1 percent of vascular and endovascular surgeons nationwide for 2011, 2012, 2013 and 2014 by U.S. News and World Report. He received a Lifetime Achievement Award from the Delaware Valley Vascular Society last year.

Find out what's happening in Moorestownfor free with the latest updates from Patch.

Carpenter joined Cooper in 2008 as Chief of the Department of Surgery. His entire career has been focused on vascular and endovascular surgery, including a commitment to research and education. His special interests include abdominal and thoracic aortic aneurysms, carotid arterial disease, peripheral vascular disease and endovascular surgery.

Carpenter’s experience includes serving on the editorial boards of the Journal of Vascular Surgery, Vascular and Endovascular Surgery, the Journal of Vascular and Endovascular Therapy, Vascular and several other journals. He’s had more than 250 papers published.

Find out what's happening in Moorestownfor free with the latest updates from Patch.

In January of 2014, vascular surgeons at Cooper were the first in North America to treat abdominal aortic aneurysms (AAA) with a new generation sealing system when they implanted the first, investigational Nellix EVAS graft from Endologix as part of a global, multi-center clinical trial.

Carpenter serves as the study's Global Principal Investigator. Results of the 30-day study were recently published in the Journal of Vascular Surgery. The results showed that in selected patients, the perioperative outcomes were encouraging, achieving high procedural success with very low endoleak rate, morbidity and mortality.

"Nellix represents the first meaningful advancement in abdominal aortic aneurysm repair since endovascular grafts were introduced in the late 1990s,” Carpenter said. “This is ground-breaking treatment that will help many patients and dramatically change how we treat abdominal aortic aneurysms. I look forward to growing my new Moorestownoffice practice and bringing these innovative treatments to my patients.”

For more information or to schedule an appointment with Carpenter, call 856.342.2151.

The attached image of Dr. Jeffrey Carpenter was provided

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.